Q32 Bio Inc. Common Stock (QTTB) Stock Price

QTTBStock

$7.52+108.89%52W

Market Cap$223.87M

P/E7.51x

PEG Ratio—

Div yield—

Beta0.51

QTTB Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)17.99%

Price vs S&P 500 (4W)-26.85%

VGM Score70.52

P/E Ratio (Annual)7.51x

Book Value / Share (Quarterly)$4.46

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)155.81%

Cash Flow / Share (Quarterly)$-0.84

Price vs S&P 500 (YTD)114.58%

Net Profit Margin (TTM)107.43%

EPS (TTM)$2.29

10-Day Avg Trading Volume0.75M

EPS Excl Extra (TTM)$2.29

Revenue Growth (5Y)81.88%

EPS (Annual)$2.42

ROI (Annual)-255.53%

Net Profit Margin (5Y Avg)-2984.10%

Cash / Share (Quarterly)$4.48

P/E Basic Excl Extra (TTM)7.51x

P/E Normalized (Annual)7.51x

ROA (Last FY)-51.88%

EBITD / Share (TTM)$1.27

ROE (5Y Avg)-224.01%

Operating Margin (TTM)85.38%

Cash Flow / Share (Annual)$-5.65

P/B Ratio2.11x

P/B Ratio (Quarterly)2.04x

Net Income / Employee (Annual)$1,242,500

ROA (TTM)45.06%

EV / EBITDA (TTM)7.49x

EPS Incl Extra (Annual)$2.42

Current Ratio (Annual)5.13x

Quick Ratio (Quarterly)19.80x

3-Month Avg Trading Volume1.12M

52-Week Price Return108.89%

P/E Incl Extra (TTM)7.51x

Revenue / Employee (TTM)$2,239,000

P/S Ratio (Annual)4.17x

Asset Turnover (Annual)0.01x

52-Week High$23.57

Operating Margin (5Y Avg)-2631.48%

EPS Excl Extra (Annual)$2.42

CapEx CAGR (5Y)-67.85%

26-Week Price Return27.89%

Quick Ratio (Annual)4.92x

13-Week Price Return-50.03%

Total Debt / Equity (Annual)2.29x

Current Ratio (Quarterly)20.30x

Enterprise Value$117.60M

Revenue / Share Growth (5Y)136.64%

Asset Turnover (TTM)0.87x

Revenue / Employee (Annual)$2,239,000

Pretax Margin (Annual)55.49%

Cash / Share (Annual)$6.50

3-Month Return Std Dev59.72%

Net Income / Employee (TTM)$1,242,500

ROE (Last FY)-840.37%

EPS Basic Excl Extra (Annual)$2.42

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$2.29

ROI (TTM)111.62%

P/S Ratio (TTM)4.17x

Pretax Margin (5Y Avg)-2497.64%

Revenue / Share (Annual)$4.36

Price vs S&P 500 (52W)93.36%

P/E Ratio (TTM)7.51x

Year-to-Date Return126.51%

5-Day Price Return-13.96%

EPS Normalized (Annual)$2.42

ROA (5Y Avg)-56.34%

Net Profit Margin (Annual)55.49%

Month-to-Date Return-9.07%

EBITD / Share (Annual)$1.27

Operating Margin (Annual)28.48%

ROI (5Y Avg)-107.04%

P/E Excl Extra (TTM)7.51x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$2.29

P/B Ratio (Annual)8.38x

Pretax Margin (TTM)107.43%

Book Value / Share (Annual)$0.42

Price vs S&P 500 (13W)-52.72%

Beta0.51x

P/FCF (Annual)49.53x

Revenue / Share (TTM)$4.26

ROE (TTM)137.41%

52-Week Low$1.91

vGradeB

gGradeA

mGradeC

vgmGradeB

QTTB Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	-$0.54	-$0.44	+18.82%(+$0.10)
Q1 2026	May 5, 2026	-$0.68	-$0.54	+20.59%(+$0.14)
Q4 2025	Mar 10, 2026	-$0.86	$4.58	+632.56%(+$5.44)
Q3 2025	Nov 13, 2025	-$1.19	-$0.60	+49.58%(+$0.59)
Q2 2025	Aug 6, 2025	-$0.98	-$0.78	+20.41%(+$0.20)

QTTB Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.09

4.18

4.17

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
QTTBQ32 Bio Inc. Common Stock	B	A	C	4.2x	—	—	—	$7.52
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company developing antibody-based therapeutics for autoimmune and inflammatory diseases. The company targets key pathways in both adaptive immunity (T and B cells) and innate immunity to restore immune balance. Q32's approach is designed to provide safe and effective treatment options for patients with pathological immune dysfunction.

QTTB Insider Transactions

SellAug 25, 2026
MORRISON JODIE POPE
Chief Executive Officer
Shares: 9,845Value: $163,033
SellAug 25, 2026
KALOWSKI LEE
President
Shares: 3,972Value: $65,776
SellAug 25, 2026
VIOLETTE SHELIA M
Officer
Shares: 2,798Value: $46,335

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for August 2026

Companies in Related Industries

PTNMPitanium Limited Class A Ordinary sharesCosmetics & Toiletries
CABACabaletta Bio, Inc. Common StockBiological Products
IKTInhibikase Therapeutics, Inc. Common StockBiological Products
SABSSAB Biotherapeutics, Inc. Common StockBiological Products
LXEOLexeo Therapeutics, Inc. Common StockBiological Products
FATEFate Therapeutics, Inc.Biological Products
PLXProtalix BioTherapeutics, Inc. Common StockBiological Products
ALECAlector, Inc. Common StockBiological Products

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.2

Buy

Consensus rating

52-Week Range

Low$1.91

High$23.57